Prasad said there was a need for the government to focus on and invest more in primary healthcare

An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India

The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019

In September last year, a committee on National List of Essential Medicines (NLEM) had set up sub-committees to classify medicines, medical devices, disposables, and health and hygiene products as per their criticality for the healthcare.

The growing popularity of Patanjali's products has caused discomfort among the firm's international rivals who are out to malign it by spreading lies, yoga guru Ramdev's company said on Tuesday.

Domestic cancer drug sales are growing at 20 per cent annually for the past few years, while global growth is half of that

The buzz is that Ranjan Pai-owned Manipal Hospitals has begun confirmatory due diligence on Medanta assets and an agreement is likely to be signed in the next 60 days

The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.

In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.

The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases

In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits

New think tank to build India's case in pharma, healthcare with the world